ProfileGDS5822 / ILMN_1233640
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 29% 37% 51% 6% 2% 45% 42% 14% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.229
GSM1276600PDAC Late Ablation Control 219.437
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 119.951
GSM1276603PDAC Late Ablation 26.86
GSM1276604PDAC Late Ablation 32.92
GSM1303940PDAC Late Ablation_anti-CTLA4 120.245
GSM1303941PDAC Late Ablation_anti-CTLA4 220.342
GSM1303942PDAC Late Ablation_anti-CTLA4 38.214